In addition to CRBN, several other PROTACs have been developed employing different E3 enzymes such as CRL2 VHL 113,114,115 , suggesting that PROTAC could be developed as a platform technology
The implementation of standardized protocols has been shown to significantly reduce adverse events in non operating room settings, with some studies suggesting reductions of up to 40 percent
doi:10.1016/j.rbmo.2020.08.013
This minimizes blockage of the nasal membrane and also optimizes absorption
We don't endorse or list specific peptide companies
A reasonable decision should therefore be based on formulation quality, dose, tolerance, convenience, clinical purpose and individual response rather than a marketing claim that one form always wins